Liangfeng Han

Title: Innovations of Liangfeng Han in Breast Neoplasia Research

Introduction

Liangfeng Han is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical research, particularly in the area of breast neoplasia. His innovative work focuses on the therapeutic and diagnostic potential of the HEYL transcription factor.

Latest Patents

Liangfeng Han holds a patent titled "HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses therefor." This invention features compositions and methods that are useful for treating or diagnosing neoplasia, specifically breast neoplasia. The invention is based on the observation that the basic helix loop helix transcription factor HEYL is overexpressed in breast cancer cells. The patent provides therapeutic compositions and methods for altering the levels and expression of HEYL, thereby offering new avenues for treating neoplasia.

Career Highlights

Liangfeng Han is affiliated with Johns Hopkins University, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer treatment and diagnosis. With a focus on innovative solutions, he continues to advance the understanding of neoplasia.

Collaborations

Liangfeng Han collaborates with Saraswati Vaidyanathan Sukumar, enhancing the research efforts in the field of breast cancer. Their partnership exemplifies the importance of teamwork in scientific discovery.

Conclusion

Liangfeng Han's contributions to breast neoplasia research through his patent and collaboration with esteemed colleagues highlight the ongoing efforts to improve cancer diagnosis and treatment. His work represents a significant step forward in the fight against breast cancer.